Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22100,795,1.05 [0.96-1.15],0.3046596589442519
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22101,129,1.12 [0.89-1.41],0.3477739925691149
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23502,138,1.22 [0.98-1.52],0.0784610694945182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17522,439,1.10 [0.97-1.25],0.1328069967586166
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23445,81,1.02 [0.76-1.36],0.8999598334352062
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22800,69,0.83 [0.60-1.15],0.2694751795201783
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24338,80,1.04 [0.78-1.39],0.7995196636928097
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24356,54,0.92 [0.65-1.32],0.6667595118791563
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22317,40,1.44 [0.98-2.13],0.0652800185808795
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23894,96,1.01 [0.77-1.32],0.953717425123756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23857,59,0.75 [0.53-1.07],0.1095868951848441
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24396,58,1.17 [0.84-1.64],0.3601418985197616
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24360,92,1.13 [0.86-1.48],0.372064981119149
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24352,84,1.11 [0.84-1.47],0.4563471533791302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Mycoses,24187,44,1.16 [0.79-1.71],0.4512068414302045
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23620,339,0.97 [0.84-1.12],0.6925943054617705
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23407,126,1.13 [0.90-1.42],0.2938107926743932
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23501,220,0.93 [0.78-1.11],0.4088084229664245
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",21125,28,0.95 [0.57-1.56],0.829009361106991
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21142,45,0.88 [0.59-1.31],0.5179421398079148
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21210,113,1.16 [0.91-1.49],0.2258881859563505
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21215,118,1.17 [0.92-1.49],0.2010074495448074
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11850,260,0.93 [0.79-1.10],0.415408212694057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9529,22,1.68 [0.97-2.90],0.062255699529193
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21141,44,1.01 [0.68-1.50],0.953599865378599
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22554,719,1.11 [1.01-1.23],0.0312873493337046
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23481,183,1.10 [0.91-1.34],0.3148975154263209
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24035,73,0.87 [0.64-1.18],0.3619523617318481
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24463,69,1.05 [0.77-1.44],0.7636385038755533
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Rectum,24253,43,1.61 [1.10-2.36],0.0151951727896865
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24462,34,1.01 [0.65-1.59],0.958697898438818
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm: Stomach,24500,27,0.97 [0.58-1.61],0.906157629227438
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm,24233,263,0.91 [0.77-1.07],0.26622347365606
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24444,108,0.86 [0.66-1.11],0.2364357431941196
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24447,79,0.87 [0.64-1.17],0.354557486623211
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24415,43,0.71 [0.47-1.06],0.0952239860624925
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,"Haemangioma, any site",24417,43,0.71 [0.47-1.06],0.0952485745899482
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi,24319,212,0.99 [0.83-1.19],0.936932660638468
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24465,96,1.15 [0.88-1.50],0.2993531155060299
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Other benign neoplasms of skin,24377,162,0.98 [0.79-1.20],0.8172705881638862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Benign neoplasm of breast,13494,80,1.03 [0.77-1.39],0.8223922067433055
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter II Neoplasms,Leiomyoma of uterus,13186,605,1.07 [0.96-1.19],0.240723652860506
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23624,168,1.18 [0.97-1.44],0.1019440508866257
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23524,311,1.10 [0.95-1.28],0.1885756321584711
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23524,311,1.10 [0.95-1.28],0.1885756321584711
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22426,311,1.14 [0.98-1.32],0.0939591994254156
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24060,73,0.80 [0.59-1.10],0.1719067163104723
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24281,89,1.06 [0.80-1.39],0.7014532315627238
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21477,628,1.16 [1.05-1.30],0.0050603664571007
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23383,379,1.05 [0.92-1.20],0.4630099399901674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22889,91,0.88 [0.66-1.16],0.3550047344995624
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23821,51,0.87 [0.60-1.25],0.4468221236766473
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22877,79,0.87 [0.64-1.17],0.3525222188895796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,23082,284,1.08 [0.92-1.27],0.3306671622742201
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23075,277,1.08 [0.92-1.27],0.3553474792812723
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22794,156,0.95 [0.75-1.19],0.6510405879489078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22798,154,0.96 [0.76-1.21],0.7362295238541761
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21336,487,1.09 [0.96-1.23],0.1856354247135651
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20916,67,0.85 [0.62-1.19],0.3504687062119664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,21296,447,1.10 [0.97-1.25],0.1306191899493346
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20890,41,1.56 [1.06-2.30],0.0250010989241208
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20913,64,1.28 [0.93-1.77],0.1317450530643638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Any mental disorder,21244,682,1.05 [0.95-1.17],0.3238939940460318
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20831,269,1.03 [0.87-1.21],0.747171580822748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24126,203,0.96 [0.80-1.16],0.7068276240435238
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24180,147,1.02 [0.83-1.27],0.8239065500144516
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22747,73,0.81 [0.59-1.10],0.1781383167254179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24402,73,0.79 [0.58-1.08],0.1326928072844305
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20635,73,0.80 [0.58-1.09],0.1580295672739684
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Alcohol dependence,22762,88,0.91 [0.68-1.21],0.5143288442888898
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Smoking dependency,22717,64,1.29 [0.93-1.79],0.128381484058846
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20631,69,0.88 [0.64-1.21],0.4366928844072308
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20900,338,1.05 [0.91-1.22],0.4756833253176613
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression,22971,293,1.07 [0.92-1.25],0.3985601900869434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Depression or dysthymia,20773,256,1.09 [0.93-1.29],0.2881958195472591
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20689,127,1.24 [0.99-1.56],0.0606787667433668
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter V Mental and behavioural disorders,Other anxiety disorders,23183,56,1.03 [0.72-1.46],0.8811791793571482
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Neurological diseases,21812,1298,1.04 [0.96-1.12],0.3417712238776177
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20320,159,1.01 [0.82-1.24],0.9367099535443087
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24312,129,1.03 [0.81-1.29],0.8303543119998681
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23325,434,1.05 [0.92-1.19],0.4590263824527237
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Epilepsy,23040,149,0.89 [0.72-1.11],0.3035299551054039
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Migraine,22979,88,1.15 [0.87-1.51],0.3309138650236081
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24173,79,1.16 [0.87-1.55],0.3159980081798474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24072,37,0.96 [0.62-1.48],0.8401877832928423
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other sleep disorders,23043,152,1.13 [0.91-1.40],0.2642666240948416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Sleep apnoea,23954,118,1.13 [0.89-1.44],0.3130680615166392
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23499,545,1.01 [0.90-1.13],0.9247095116587432
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23078,124,1.06 [0.84-1.34],0.6352461028366747
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23245,291,0.98 [0.84-1.15],0.8398970196583275
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24309,79,1.03 [0.77-1.38],0.8566686985045435
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Hemiplegia,24282,52,0.89 [0.62-1.29],0.5458208062838443
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Other neurological diseases,24120,109,0.91 [0.70-1.17],0.4500435496366936
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24087,278,1.05 [0.89-1.22],0.5800801014266332
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23958,149,1.13 [0.91-1.40],0.2662002227779503
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23889,80,0.92 [0.69-1.24],0.6032589442962428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23898,89,1.07 [0.81-1.41],0.6359183806690794
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23852,43,1.18 [0.80-1.74],0.4138950862517442
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22967,56,1.05 [0.74-1.48],0.793576256155722
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23078,167,1.03 [0.84-1.26],0.777218613164921
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23955,110,1.07 [0.84-1.38],0.5782258176254632
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24280,18,1.43 [0.79-2.58],0.2319001246221566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1554,18,1.27 [0.69-2.33],0.4366551486312872
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22744,18,1.45 [0.81-2.59],0.2164452011422672
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24165,43,1.09 [0.74-1.62],0.6579342530995282
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24145,23,0.85 [0.49-1.48],0.5665437628115302
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24084,85,0.75 [0.56-1.00],0.0533739488987079
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24132,88,0.98 [0.74-1.30],0.8971428481719179
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24384,113,0.95 [0.74-1.22],0.6859079146471649
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,24029,86,1.11 [0.84-1.46],0.4746735132056173
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19120,1739,1.08 [1.01-1.16],0.0271824526831735
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24221,37,0.78 [0.50-1.21],0.2671484625995169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, essential",20055,1162,1.12 [1.03-1.22],0.0079560764323636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertension,20072,1179,1.11 [1.02-1.21],0.0115536098821554
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18926,33,1.00 [0.63-1.58],0.9846686247077108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23178,503,0.95 [0.84-1.07],0.405935311827321
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Angina pectoris,22981,306,0.93 [0.80-1.09],0.3653472778558047
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23869,119,0.87 [0.68-1.11],0.2776724862280192
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23974,224,0.89 [0.74-1.06],0.1874501514625987
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24406,49,0.74 [0.51-1.09],0.1320095758722197
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22813,138,0.94 [0.75-1.18],0.6121087268588843
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23044,379,0.94 [0.82-1.08],0.3853786194971803
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24044,77,0.99 [0.73-1.33],0.9359259334902656
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24048,158,0.97 [0.78-1.19],0.7574214789476174
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24026,59,1.09 [0.78-1.53],0.6047061438192702
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24027,60,1.10 [0.79-1.54],0.5597009105955826
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18949,56,1.10 [0.78-1.56],0.5898580477289636
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22170,41,0.93 [0.62-1.40],0.7245468030235794
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Conduction disorders,22196,67,1.18 [0.86-1.62],0.2959377041010844
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16666,85,1.36 [1.03-1.80],0.0294825146866801
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16755,174,1.15 [0.94-1.40],0.1747812132881323
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other arrhythmias,22164,35,1.44 [0.94-2.20],0.0906142800828338
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22183,54,0.81 [0.56-1.17],0.2657346379192599
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24049,110,1.18 [0.92-1.51],0.1915598369633967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24025,100,1.07 [0.82-1.39],0.6191921963764985
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24056,75,1.24 [0.92-1.67],0.1526884470850505
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24099,64,1.22 [0.88-1.68],0.231755520854648
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23836,44,0.99 [0.67-1.48],0.974651789077094
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23865,73,1.01 [0.74-1.37],0.9695527583700668
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23425,102,1.08 [0.83-1.39],0.5797899304290676
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23408,85,1.12 [0.84-1.48],0.4455667337295709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24361,82,1.15 [0.86-1.53],0.3439268766269322
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Varicose veins,23708,385,0.86 [0.75-0.99],0.0307453748954565
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,Hypotension,23854,45,1.10 [0.74-1.62],0.6412874524131168
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20732,1726,1.09 [1.02-1.17],0.0079253108612315
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24301,121,1.11 [0.88-1.41],0.3725730566832989
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23449,164,1.19 [0.97-1.45],0.095871332577948
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23427,142,1.13 [0.91-1.41],0.2599434309122285
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23949,197,1.04 [0.86-1.25],0.6887310167157331
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23948,196,1.04 [0.86-1.25],0.7138503116290396
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23710,584,1.05 [0.95-1.18],0.3378479156527411
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic sinusitis,23218,92,1.20 [0.92-1.57],0.1785161379233618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Nasal polyp,23223,97,1.08 [0.83-1.40],0.5817791024771053
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23500,374,1.08 [0.95-1.24],0.2462939136244246
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Deviated nasal septum,23322,196,1.14 [0.95-1.37],0.1729184270163649
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14076,45,1.16 [0.78-1.72],0.4597556151873903
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22410,782,1.05 [0.96-1.16],0.2776237224903434
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Early onset COPD,23868,94,1.00 [0.77-1.32],0.9730494079654674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23868,94,1.00 [0.77-1.32],0.9730494079654674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23868,94,1.00 [0.77-1.32],0.9730494079654674
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22936,708,1.04 [0.94-1.15],0.4688714903835206
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Asthma,18720,708,1.04 [0.94-1.15],0.39927493839849
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18585,708,1.04 [0.94-1.15],0.4121353977776062
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18705,693,1.04 [0.94-1.15],0.4360440114093188
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24332,56,1.33 [0.95-1.87],0.1021847771179574
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Interstitial lung disease,23304,42,1.06 [0.71-1.58],0.7805953212578098
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",24389,42,1.07 [0.71-1.59],0.7538573258602141
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23298,36,1.03 [0.67-1.59],0.8836221984857618
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Pleural effusion,23305,70,1.30 [0.96-1.76],0.0889394885767397
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other diseases of pleura,23399,164,1.26 [1.04-1.55],0.0214232881268809
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23750,75,1.47 [1.10-1.96],0.0095834646458251
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17404,4569,1.04 [0.99-1.09],0.0849269162827266
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23968,441,1.03 [0.91-1.17],0.6584196321912763
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24441,122,0.97 [0.77-1.23],0.8075796479778372
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Impacted teeth,24446,112,0.99 [0.77-1.26],0.9054466259027352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Dental caries,23636,109,1.08 [0.84-1.38],0.5491291787244589
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23628,101,1.05 [0.81-1.36],0.7375734251781081
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24428,137,1.02 [0.81-1.27],0.8937562232426862
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23609,82,1.18 [0.88-1.56],0.2653768173878269
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23387,56,0.83 [0.58-1.19],0.3089341768013093
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24390,41,0.68 [0.45-1.04],0.0771104319097048
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19702,186,0.97 [0.80-1.18],0.7606091326952751
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21071,1555,1.02 [0.96-1.10],0.4849731646624131
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophagitis,19753,237,1.13 [0.96-1.34],0.1448691203266972
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20018,502,1.02 [0.90-1.15],0.7640103044489344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19577,61,1.23 [0.89-1.72],0.2127396660733971
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19641,125,1.04 [0.82-1.31],0.7428570128865742
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19541,25,1.29 [0.77-2.15],0.3272979683173521
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Gastric ulcer,19608,92,0.96 [0.73-1.26],0.7854457809598645
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Duodenal ulcer,19612,96,0.92 [0.70-1.21],0.5497155649539629
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24408,67,0.88 [0.64-1.22],0.4562197809321638
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Chronic gastritis,19611,95,0.92 [0.70-1.21],0.5682067811852033
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20084,568,1.03 [0.92-1.16],0.5639787240295804
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of appendix,24339,143,0.97 [0.78-1.20],0.7579763512238702
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Functional dyspepsia,19857,341,1.09 [0.95-1.26],0.2328925002849537
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19617,101,0.83 [0.63-1.08],0.1624555833986518
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24325,173,0.95 [0.77-1.16],0.5867381057685841
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute appendicitis,24308,112,0.90 [0.70-1.16],0.4120731200881997
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Hernia,22093,1046,1.03 [0.95-1.12],0.4402419619241371
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Inguinal hernia,21396,349,1.03 [0.90-1.19],0.6613045472709476
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Umbilical hernia,21150,103,0.97 [0.75-1.26],0.8339593138157215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ventral hernia,21126,79,0.82 [0.61-1.11],0.2018003716799563
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21590,543,1.07 [0.96-1.20],0.2178547705005813
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23734,665,1.19 [1.08-1.32],0.0006724212903513
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestines,20166,1472,1.02 [0.95-1.09],0.6371579962371902
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24207,65,1.09 [0.79-1.50],0.5907290126142304
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24428,92,1.20 [0.92-1.57],0.1769920245662108
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn disease,23161,92,1.21 [0.93-1.58],0.1596987028656068
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23141,72,1.19 [0.88-1.60],0.2698751967390226
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24377,115,1.10 [0.86-1.40],0.4447768361768065
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Ulcerative colitis,23184,115,1.11 [0.87-1.41],0.4150759691946625
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23167,98,1.08 [0.83-1.41],0.5542004647273359
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23604,535,1.23 [1.10-1.37],0.0003774284928026
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23600,531,1.23 [1.10-1.37],0.0003652411905568
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18758,64,1.15 [0.83-1.58],0.4118802025949951
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal stricture,24192,64,1.14 [0.82-1.57],0.4430277596413405
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18740,46,1.10 [0.75-1.61],0.6380780773263883
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18963,269,1.10 [0.93-1.29],0.2634020568926617
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18842,148,1.08 [0.87-1.34],0.4752578302006592
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18915,221,1.32 [1.11-1.57],0.0016223806210828
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Constipation,23481,197,1.31 [1.09-1.58],0.0034664995731017
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24123,79,1.12 [0.84-1.50],0.4450711816337901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18856,162,0.94 [0.76-1.16],0.5575131488218381
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18779,85,0.98 [0.74-1.30],0.8722589664456564
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19397,703,0.97 [0.88-1.08],0.5845881705121438
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of intestine,18854,160,0.81 [0.65-1.00],0.053322297380983
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24111,67,1.11 [0.81-1.52],0.5320052039635064
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of liver,23852,110,0.76 [0.59-0.98],0.0332670335224877
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of liver,23805,63,0.77 [0.55-1.08],0.1256115957522243
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23388,461,1.05 [0.93-1.18],0.4657337928682669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholelithiasis,23295,368,1.02 [0.89-1.18],0.726063280574597
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Cholecystitis,22994,67,1.16 [0.85-1.59],0.3475787466853297
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22964,37,1.19 [0.78-1.83],0.4141756976804158
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis,22976,49,0.75 [0.51-1.10],0.1427926201917548
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24338,49,0.73 [0.50-1.07],0.1113265636370923
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23400,252,1.08 [0.92-1.28],0.3429353041091907
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23209,61,1.05 [0.75-1.46],0.7963631804240608
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Coeliac disease,23198,50,1.01 [0.69-1.46],0.97079232195329
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23188,40,1.30 [0.87-1.94],0.2055965226967834
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23303,155,1.11 [0.90-1.37],0.3228761864741498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XI Diseases of the digestive system,GI-bleeding,23298,150,1.09 [0.88-1.35],0.4345989339999754
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22218,1305,0.97 [0.90-1.05],0.4608389448353085
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24161,89,1.02 [0.77-1.35],0.8835024240896218
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24128,412,0.99 [0.87-1.13],0.9339202488306408
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23513,459,0.94 [0.83-1.06],0.3295113405838598
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23800,360,1.01 [0.87-1.16],0.939521939713796
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23536,96,0.84 [0.64-1.11],0.2163186184772431
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23641,201,1.02 [0.85-1.23],0.8254481821176215
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24275,74,0.87 [0.64-1.19],0.3882139987636207
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24263,62,0.93 [0.66-1.30],0.6629350290495257
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24247,46,0.94 [0.64-1.39],0.7706423541128637
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24358,28,0.83 [0.50-1.37],0.4701395493984929
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24355,25,0.82 [0.48-1.40],0.4645232580678805
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23775,59,1.20 [0.86-1.68],0.2789711412752454
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24028,312,0.99 [0.85-1.15],0.8601912140782512
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23113,59,0.88 [0.62-1.24],0.4614529281411106
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23142,88,0.82 [0.62-1.09],0.1667888132810344
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23128,74,0.85 [0.62-1.16],0.3026731247813701
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23230,176,0.99 [0.81-1.21],0.89568801933152
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23208,154,0.88 [0.71-1.09],0.2467986576408029
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18962,3102,1.00 [0.95-1.06],0.8949546000314037
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20370,1654,0.99 [0.93-1.06],0.830665118245167
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22337,969,1.13 [1.04-1.23],0.0041813350616748
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18827,111,0.99 [0.77-1.27],0.9491347614369654
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19027,311,0.95 [0.82-1.11],0.5498902017983416
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24200,106,1.02 [0.79-1.31],0.89395046186121
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24212,94,0.99 [0.76-1.30],0.9444745535702188
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19306,590,1.02 [0.91-1.14],0.7863391337430832
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21577,590,1.01 [0.91-1.13],0.8065174287070884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18755,39,1.06 [0.70-1.60],0.7961072614549356
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24163,38,1.06 [0.69-1.62],0.7811730570838967
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18850,134,0.85 [0.68-1.08],0.1785825735674204
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18738,22,1.21 [0.70-2.11],0.4938383117226695
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18830,114,0.94 [0.73-1.20],0.606223254504763
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24400,58,0.91 [0.64-1.29],0.6095723950313057
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19011,295,1.03 [0.89-1.21],0.6713234036375573
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18913,197,1.03 [0.85-1.25],0.7382412263440536
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19805,1089,1.00 [0.92-1.08],0.9499215704459428
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18754,38,1.32 [0.87-2.00],0.1938248330527683
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18871,155,0.96 [0.78-1.20],0.7441116998412307
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18741,25,0.96 [0.57-1.64],0.8944803692595095
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18742,26,1.07 [0.64-1.79],0.7930783504959459
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19166,450,1.01 [0.89-1.14],0.9212548962703352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19091,375,1.02 [0.89-1.17],0.8169570616539126
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19346,247,1.03 [0.87-1.22],0.7460296155249926
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24138,146,0.90 [0.72-1.12],0.3284828220855291
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24029,37,0.84 [0.54-1.30],0.4307663576491756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21877,45,0.89 [0.60-1.33],0.5738086750825839
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22029,197,0.84 [0.69-1.01],0.0658495798744309
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22636,804,0.96 [0.87-1.05],0.3705992488722336
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21955,123,0.99 [0.78-1.26],0.9441627244225046
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21882,50,0.61 [0.41-0.89],0.0103211013932706
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22512,680,0.99 [0.89-1.09],0.8091796582674186
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21883,51,0.96 [0.67-1.39],0.8437491696951831
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22063,231,1.05 [0.89-1.25],0.5630759914338288
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21933,101,0.99 [0.76-1.29],0.9532065393615664
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21892,60,1.05 [0.75-1.48],0.7638884023120582
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21958,126,0.90 [0.71-1.14],0.3786117361458812
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21893,61,1.06 [0.76-1.49],0.7169031290279495
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22125,293,1.11 [0.95-1.29],0.1887513496270653
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21614,246,1.07 [0.91-1.26],0.4261447305558447
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21416,48,1.00 [0.68-1.46],0.994906148806018
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21412,44,0.99 [0.66-1.47],0.94993111391864
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21471,103,1.12 [0.87-1.45],0.3697714576922797
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21419,51,1.27 [0.89-1.82],0.192059456253141
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21424,56,1.40 [1.00-1.97],0.0523710343306182
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21410,42,1.31 [0.88-1.94],0.1834204243097298
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21553,185,0.96 [0.79-1.17],0.7086088228554631
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21415,47,1.07 [0.73-1.56],0.7424767008377533
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21412,44,1.26 [0.86-1.86],0.2402676584425394
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21459,91,0.89 [0.67-1.17],0.3947983292166359
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21434,66,0.85 [0.61-1.18],0.3260674102414653
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21761,393,1.18 [1.03-1.34],0.0158669547964234
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21504,136,1.05 [0.84-1.31],0.6929952618900999
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21573,205,1.29 [1.08-1.54],0.0054877036685474
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23253,92,0.95 [0.72-1.26],0.726603567521144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23460,299,0.92 [0.79-1.08],0.2998042818022377
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23211,50,0.85 [0.59-1.24],0.3985151341482096
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23216,55,1.02 [0.72-1.46],0.9044399691348568
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23263,102,0.94 [0.73-1.22],0.6539337081195975
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20736,3844,1.02 [0.97-1.06],0.5095172217747399
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9954,349,1.06 [0.92-1.22],0.4394256424314755
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23180,162,0.96 [0.78-1.18],0.6757921651964981
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23063,45,0.97 [0.66-1.43],0.8803770774793384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23329,33,0.77 [0.48-1.24],0.2848457638871328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23327,31,1.09 [0.69-1.74],0.7051183659503408
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23335,39,1.11 [0.73-1.68],0.6256439588104498
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24177,211,1.12 [0.93-1.33],0.232678278007695
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24240,48,1.22 [0.84-1.76],0.3031799402082078
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24111,145,1.04 [0.84-1.29],0.7394675894518326
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24053,87,1.29 [0.98-1.70],0.0641476839206188
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23151,777,0.99 [0.89-1.08],0.7588551348834247
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Cystitis,22444,70,0.91 [0.66-1.25],0.557263655833065
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22432,58,1.20 [0.86-1.69],0.2803649951718938
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22527,153,1.16 [0.94-1.43],0.1655901748242126
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22456,82,1.01 [0.75-1.34],0.9671767407317848
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22923,549,1.00 [0.89-1.12],0.9666466399993352
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9665,60,1.28 [0.92-1.79],0.145941590998223
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9636,31,0.89 [0.55-1.43],0.6182529678028077
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Hydrocele,9638,33,1.01 [0.64-1.58],0.96384553995901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9677,72,1.04 [0.77-1.41],0.8047992512905969
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9663,58,1.20 [0.85-1.67],0.2984217640004144
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9690,85,0.86 [0.65-1.15],0.3090210313671797
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13366,218,1.07 [0.89-1.28],0.4693466275828956
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13213,65,1.01 [0.73-1.40],0.9370442266468384
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13221,73,1.08 [0.80-1.47],0.6142104116441709
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13197,49,1.04 [0.72-1.51],0.8342286013605313
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13333,339,0.97 [0.84-1.12],0.6881028456668836
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,13065,71,0.94 [0.69-1.29],0.7133211510692383
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13163,169,1.00 [0.82-1.23],0.9689806801476286
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12293,2425,1.03 [0.97-1.10],0.3056995183993076
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Endometriosis,10123,255,1.15 [0.97-1.36],0.0995163015240289
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9949,81,1.32 [0.99-1.76],0.0615946836334025
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9968,100,1.08 [0.83-1.41],0.5560521278402611
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10142,274,1.13 [0.96-1.33],0.1315773408251275
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10136,268,0.91 [0.77-1.08],0.2751961256890881
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10287,419,0.98 [0.86-1.11],0.7294304081555446
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Uterine polyps,10012,144,0.97 [0.78-1.21],0.789180444507789
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10057,189,1.17 [0.97-1.42],0.0990477676428701
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9941,73,1.26 [0.93-1.71],0.1391226680994822
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9996,128,1.24 [0.98-1.56],0.0754204547091912
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13498,177,1.25 [1.03-1.53],0.0234379216982946
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13507,170,1.23 [1.01-1.51],0.0393144451301485
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13523,95,1.24 [0.95-1.63],0.1085642036386598
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13515,103,1.28 [0.99-1.65],0.0623637289020374
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9930,62,0.87 [0.62-1.21],0.4023741445434662
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9920,52,0.94 [0.65-1.36],0.7259301532250079
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9930,62,0.82 [0.58-1.16],0.2683531971566756
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Irregular menses,13436,333,1.19 [1.03-1.37],0.0189601391514508
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10868,1000,1.07 [0.98-1.17],0.1116760312100338
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10548,680,1.03 [0.93-1.14],0.6127873657230732
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13509,145,1.04 [0.84-1.29],0.7248639502370133
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10179,311,0.93 [0.80-1.08],0.3355717192965615
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,10098,230,1.02 [0.86-1.22],0.8122655369931884
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10097,229,1.09 [0.91-1.29],0.3638355104993269
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,Female infertility,9956,88,1.16 [0.87-1.55],0.3107244292455247
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9949,81,1.12 [0.83-1.52],0.4504946722883445
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13517,735,1.01 [0.91-1.13],0.8042979512271584
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13524,1011,1.07 [0.97-1.17],0.1979095585688735
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13518,397,1.13 [0.98-1.30],0.0826359324290596
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13233,112,1.26 [0.98-1.61],0.0722928828895851
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13280,159,1.01 [0.82-1.26],0.8921909653929038
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13262,141,1.24 [0.99-1.55],0.0645929468689035
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13533,143,1.00 [0.80-1.25],0.9843944708104
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13535,141,0.98 [0.78-1.23],0.8659477826469746
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13532,366,0.92 [0.79-1.06],0.2449086321282328
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13274,108,0.72 [0.55-0.94],0.0167109751319461
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13371,205,0.94 [0.78-1.14],0.5466642855124391
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12906,124,1.15 [0.90-1.47],0.2587174935694669
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12952,170,0.97 [0.78-1.20],0.7688221012349657
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12985,203,1.03 [0.85-1.25],0.752381030769554
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12907,125,0.97 [0.75-1.24],0.7875773466579143
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12897,115,1.09 [0.84-1.40],0.5213933191430598
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12909,127,0.84 [0.66-1.08],0.1794715977860901
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12707,194,1.11 [0.91-1.35],0.2963153380014514
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12891,378,1.00 [0.87-1.16],0.9567175708262566
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,13071,558,1.09 [0.97-1.24],0.1631359609969657
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13538,148,1.09 [0.87-1.36],0.4526024090732577
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12312,113,1.05 [0.81-1.35],0.7230960903506904
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12598,85,0.91 [0.68-1.23],0.5510609259566579
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13543,289,0.95 [0.81-1.12],0.5486335864872378
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13478,224,0.92 [0.77-1.11],0.4068062341322169
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13532,213,1.10 [0.91-1.32],0.3344038349455587
USP25,Ubiquitin carboxyl-terminal hydrolase 25,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13522,203,1.11 [0.91-1.34],0.3038326356890229
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24278,31,0.72 [0.45-1.18],0.1920491723995737
USP25,Ubiquitin carboxyl-terminal hydrolase 25,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23030,452,0.91 [0.80-1.03],0.1213936553056651
